EARNINGS (LOSS) PER SHARE

6 Months Ended

Jun. 30, 2020

Basic earnings (loss) per share is computed by dividing net loss attributable to American Renal Associates Holdings, Inc., net of the change in the difference between the redemption value and estimated fair value for accounting purposes of the related noncontrolling interest put provisions, by the weighted-average number of common shares outstanding during the applicable period, less unvested restricted stock. Diluted earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the applicable period, plus the dilutive effect of outstanding options, using the treasury stock method and the average market price of the Company’s common stock during the applicable period. Certain shares related to some of the Company’s outstanding stock options were excluded from the computation of diluted earnings (loss) per share because they were anti-dilutive in the periods presented but could be dilutive in the future.


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Basic
Net income (loss) attributable to American Renal Associates Holdings, Inc.	$	795	$	(8,178)	$	(6,439)	$	(18,657)
Change in the difference between the redemption value and estimated fair value for accounting purposes of the related noncontrolling interests	(444)		1,025		(703)		284
Net income (loss) attributable to common shareholders	$	351	$	(7,153)	$	(7,142)	$	(18,373)
Weighted-average common shares outstanding	32,862,637		32,275,807		32,661,238		32,232,004
Earnings (loss) per share, basic	$	0.01	$	(0.22)	$	(0.22)	$	(0.57)
Diluted
Net income (loss) attributable to American Renal Associates Holdings, Inc.	$	795	$	(8,178)	$	(6,439)	$	(18,657)
Change in the difference between the redemption value and estimated fair value for accounting purposes of the related noncontrolling interests	(444)		1,025		(703)		284
Net income (loss) attributable to common shareholders for diluted earnings per share calculation	$	351	$	(7,153)	$	(7,142)	$	(18,373)
Weighted-average common shares outstanding, basic	32,862,637		32,275,807		32,661,238		32,232,004
Weighted-average common shares outstanding, assuming dilution	34,612,591		32,275,807		32,661,238		32,232,004
Earnings (loss) per share, diluted	$	0.01	$	(0.22)	$	(0.22)	$	(0.57)
Outstanding options and restricted stock excluded as impact would be anti-dilutive	2,427,031		3,235,582		2,948,016		3,404,444